|
CN111356452A
|
|
Methods and compositions for treating neurological conditions
|
|
WO2011085213A2
|
|
Pathologically-activated therapeutics
|
|
US2011091568A1
|
|
Media conditioned by stem cells and uses therefor
|
|
US2010137448A1
|
|
Methods for Treating Neuropsychiatric Disorders with NMDA Receptor Antagonists
|
|
US2007292400A1
|
|
Media conditioned by human embryonic stem cells or other progenitor cells and uses therefor
|
|
AU6205200A
|
|
Method of reducing neuronal injury or apoptosis
|
|
US4348205A
|
|
Measuring beta-hydroxybutyrate concentration in urine
|
